<?xml version="1.0" encoding="utf-8"?>
<i5:EndpointStudyRecord xmlns:i5="http://echa.europa.eu/schemas/iuclid5/20130101" documentReferencePK="IUC4-aa3469aa-5a18-3b40-a217-ea5a468aebc5/0" robustStudy="false" usedForClassification="false" usedForMSDS="false" version="2013-03-28T11:56:50Z">
  <i5:modificationHistory>
    <i5:modification date="1998-06-30T22:00:00Z">
      <i5:comment>IUCLID4 last update.</i5:comment>
      <i5:modificationBy>HEDSET</i5:modificationBy>
    </i5:modification>
    <i5:modification date="1998-06-30T22:00:00Z">
      <i5:comment>Successfully migrated to IUCLID 5.2 format.</i5:comment>
      <i5:modificationBy>XML Transformation V1.0 Plug-In</i5:modificationBy>
    </i5:modification>
    <i5:modification date="1998-06-30T22:00:00Z">
      <i5:comment>Successfully migrated to IUCLID 5.3 format.</i5:comment>
      <i5:modificationBy>XML Transformation V2.0 Plug-In</i5:modificationBy>
    </i5:modification>
    <i5:modification date="1998-06-30T22:00:00Z">
      <i5:comment>Successfully migrated to IUCLID 5.4 format.</i5:comment>
      <i5:modificationBy>XML Transformation V3.0 Plug-In</i5:modificationBy>
    </i5:modification>
    <i5:modification date="1998-06-30T22:00:00Z">
      <i5:comment>Successfully migrated to IUCLID 5.5 format.</i5:comment>
      <i5:modificationBy>XML Transformation V4.0 Plug-In</i5:modificationBy>
    </i5:modification>
  </i5:modificationHistory>
  <i5:ownershipProtection sealed="false" copyProtection="false" fractionalDocument="false" />
  <i5:name>Skin sensitisation, IUC4#1/Ch.5.3</i5:name>
  <i5:ownerRef lastModificationDate="2003-09-01T22:00:00Z" type="Substance" uniqueKey="IUC4-efdb21bb-e79f-3286-a988-b6f6944d3734/0">
    <i5:description>formaldehyde (IUC4 DSN 52)</i5:description>
    <i5:notes />
  </i5:ownerRef>
  <i5:dataProtection>
    <i5:confidentiality valueID="NOT_SPECIFIED" />
    <i5:justification />
  </i5:dataProtection>
  <i5:purposeFlag valueID="NOT_SPECIFIED" />
  <i5:dataWaiving valueID="NOT_SPECIFIED" />
  <i5:dataWaivingJustification />
  <i5:studyResultType valueID="NOT_SPECIFIED">
    <i5:otherValue />
  </i5:studyResultType>
  <i5:studyPeriod />
  <i5:reliability valueID="NOT_SPECIFIED">
    <i5:otherValue />
  </i5:reliability>
  <i5:rationalReliability />
  <i5:scientificPart>
    <i5:TO_SENSITIZATION>
      <i5:REFERENCE>
        <i5:set>
          <i5:REFERENCE_AUTHOR>
            <i5:REFERENCE_AUTHOR>Magnusson, B. and Kligman, A.M.: J. Investigative|Dermatology 52, 268-276 (1969)</i5:REFERENCE_AUTHOR>
          </i5:REFERENCE_AUTHOR>
        </i5:set>
      </i5:REFERENCE>
      <i5:STUDYTYPE>
        <i5:set>
          <i5:PHRASEOTHER_LIST_POP>
            <i5:LIST_POP>813</i5:LIST_POP>
            <i5:LIST_POP.value>Guinea pig maximization test</i5:LIST_POP.value>
          </i5:PHRASEOTHER_LIST_POP>
        </i5:set>
      </i5:STUDYTYPE>
      <i5:GUIDELINE>
        <i5:set>
          <i5:QUALIFIER>
            <i5:QUALIFIER>1680</i5:QUALIFIER>
            <i5:QUALIFIER.value>according to</i5:QUALIFIER.value>
          </i5:QUALIFIER>
          <i5:PHRASEOTHER_GUIDELINE>
            <i5:GUIDELINE>701</i5:GUIDELINE>
            <i5:GUIDELINE.value>EU Method B.6 (Skin Sensitisation)</i5:GUIDELINE.value>
            <i5:GUIDELINE_TXT>Cited as Directive 84/449/EEC, B.6</i5:GUIDELINE_TXT>
          </i5:PHRASEOTHER_GUIDELINE>
        </i5:set>
      </i5:GUIDELINE>
      <i5:GLP_COMPLIANCE_STATEMENT>
        <i5:set>
          <i5:PHRASEOTHER_LIST_SEL_FIX>
            <i5:LIST_SEL_FIX>2158</i5:LIST_SEL_FIX>
            <i5:LIST_SEL_FIX.value>no</i5:LIST_SEL_FIX.value>
          </i5:PHRASEOTHER_LIST_SEL_FIX>
        </i5:set>
      </i5:GLP_COMPLIANCE_STATEMENT>
      <i5:TESTMAT_INDICATOR>
        <i5:set>
          <i5:LIST_BELOW_SEL>
            <i5:LIST_BELOW_SEL>2480</i5:LIST_BELOW_SEL>
            <i5:LIST_BELOW_SEL.value>yes</i5:LIST_BELOW_SEL.value>
          </i5:LIST_BELOW_SEL>
        </i5:set>
      </i5:TESTMAT_INDICATOR>
      <i5:TESTMAT_DETAILS>
        <i5:set>
          <i5:FREETEXT_BELOW>
            <i5:FREETEXT_BELOW>IUCLID4 Test substance: no data

TS-Freetext:
formalin, dissolved in petrolatum; no data on formaldehyde
content</i5:FREETEXT_BELOW>
          </i5:FREETEXT_BELOW>
        </i5:set>
      </i5:TESTMAT_DETAILS>
      <i5:ORGANISM>
        <i5:set>
          <i5:PHRASEOTHER_LIST_POP>
            <i5:LIST_POP>1952</i5:LIST_POP>
            <i5:LIST_POP.value>guinea pig</i5:LIST_POP.value>
          </i5:PHRASEOTHER_LIST_POP>
        </i5:set>
      </i5:ORGANISM>
      <i5:REM_RS>
        <i5:set>
          <i5:RICHTEXT_BELOW>
            <i5:RICHTEXT_BELOW>&lt;p style="font-family:Monospace;"&gt;RS-Freetext:&lt;br&gt;Twenty&amp;nbsp;female&amp;nbsp;Dunkin-Hartley&amp;nbsp;guinea&amp;nbsp;pigs&amp;nbsp;were&amp;nbsp;used.&lt;br&gt;Induction&amp;nbsp;was&amp;nbsp;carried&amp;nbsp;out&amp;nbsp;by&amp;nbsp;injecting&amp;nbsp;5%&amp;nbsp;formaldehyde&amp;nbsp;in&amp;nbsp;&lt;br&gt;petrolatum&amp;nbsp;(emulsified&amp;nbsp;in&amp;nbsp;Freund&amp;apos;s&amp;nbsp;Complete&amp;nbsp;Adjuvant)&lt;br&gt;intradermally&amp;nbsp;and,&amp;nbsp;one&amp;nbsp;week&amp;nbsp;later&amp;nbsp;by&amp;nbsp;topical&amp;nbsp;application&amp;nbsp;of&lt;br&gt;the&amp;nbsp;same&amp;nbsp;formalin&amp;nbsp;solution&amp;nbsp;under&amp;nbsp;occlusive&amp;nbsp;conditions.&lt;br&gt;Challenge&amp;nbsp;was&amp;nbsp;carried&amp;nbsp;out&amp;nbsp;two&amp;nbsp;weeks&amp;nbsp;later&amp;nbsp;by&amp;nbsp;an&amp;nbsp;application&lt;br&gt;of&amp;nbsp;2%&amp;nbsp;formalinunder&amp;nbsp;occlusive&amp;nbsp;conditions.&amp;nbsp;Sensitization&amp;nbsp;rate&lt;br&gt;was&amp;nbsp;16/20&amp;nbsp;(80%).&lt;/p&gt;</i5:RICHTEXT_BELOW>
          </i5:RICHTEXT_BELOW>
        </i5:set>
      </i5:REM_RS>
      <i5:REM_ANYOTHER>
        <i5:set>
          <i5:RICHTEXT_BELOW>
            <i5:RICHTEXT_BELOW>&lt;p style="font-family:Monospace;"&gt;RM-Freetext:&lt;br&gt;Reliability:&amp;nbsp;2&amp;nbsp;(reliable&amp;nbsp;with&amp;nbsp;restrictions)&lt;/p&gt;</i5:RICHTEXT_BELOW>
          </i5:RICHTEXT_BELOW>
        </i5:set>
      </i5:REM_ANYOTHER>
      <i5:INTERPRET_RS_SUBMITTER>
        <i5:set>
          <i5:PHRASEOTHER_LIST_POP_FIX>
            <i5:LIST_POP_FIX>2341</i5:LIST_POP_FIX>
            <i5:LIST_POP_FIX.value>sensitising</i5:LIST_POP_FIX.value>
          </i5:PHRASEOTHER_LIST_POP_FIX>
        </i5:set>
      </i5:INTERPRET_RS_SUBMITTER>
      <i5:TESTMAT>
        <i5:set>
          <i5:PHRASEOTHER_IDENTIFIER>
            <i5:IDENTIFIER>4175</i5:IDENTIFIER>
            <i5:IDENTIFIER.value>CAS number</i5:IDENTIFIER.value>
            <i5:IDENTIFIER_TXT />
          </i5:PHRASEOTHER_IDENTIFIER>
          <i5:ID>
            <i5:ID>50-00-0</i5:ID>
          </i5:ID>
        </i5:set>
        <i5:set>
          <i5:PHRASEOTHER_IDENTIFIER>
            <i5:IDENTIFIER>4178</i5:IDENTIFIER>
            <i5:IDENTIFIER.value>EC number</i5:IDENTIFIER.value>
            <i5:IDENTIFIER_TXT />
          </i5:PHRASEOTHER_IDENTIFIER>
          <i5:ID>
            <i5:ID>200-001-8</i5:ID>
          </i5:ID>
        </i5:set>
        <i5:set>
          <i5:PHRASEOTHER_IDENTIFIER>
            <i5:IDENTIFIER>4177</i5:IDENTIFIER>
            <i5:IDENTIFIER.value>EC name</i5:IDENTIFIER.value>
            <i5:IDENTIFIER_TXT />
          </i5:PHRASEOTHER_IDENTIFIER>
          <i5:ID>
            <i5:ID>formaldehyde</i5:ID>
          </i5:ID>
        </i5:set>
      </i5:TESTMAT>
    </i5:TO_SENSITIZATION>
  </i5:scientificPart>
</i5:EndpointStudyRecord>